Drug Development

Articles

Designed with safety standards in mind, flowtherm Ex incorporates a number of connectable sensors, such as vane wheel, vortex, thermal, Pt100, and other physical sensor with analog output, thereby allowing a range of applications.

Flowtherm Ex, a New Handheld Device to Monitor Explosive Atmospheres

Bosch’s market launches at the show include a new bioreactor for laboratory-scale API development, a water-for-injection unit, and a new generation of pure steam generators with high yields.

Bosch Highlights Flexible and Energy-Efficient Process Technology Solutions at ACHEMA

Products on display include the newest addition to the Mobius line of single-use bioreactors; Cellvento CHO cell culture media for optimized production of specific cell lines; and new high-volume AFS water purification systems.

A Glance of Merck Millipore’s New Solutions for Increased Efficiency

Porvair has developed a 2-ml 96 round-well deep-well plate that enables scientists to use the full 2.00 ml well capacity.

Application Optimized Microplate Products from Porvair Sciences

PSL has developed a dispensary isolator with a contained drum hoist mechanism for highly potent API production.

PSL Exhibits Nano-Containment Technology

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

In a Citizen Petition to FDA, AbbVie calls the current biosimilar labeling practices “legally unsound.”

Biosimilar Labeling Practices Under Fire in New Citizen Petition

Successful drug delivery via a dry powder inhaler is determined by the API physicochemical properties, the formulation composition and process, the device and operating conditions, the patient–device relationship, the environmental variables, and ultimately, patient compliance.

Developing an Orally Inhaled Dry Powder Formulation—A Complex Itinerary and a Technological Challenge

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Biopharma companies on both sides of the Atlantic ship more of their assay testing to outside service providers.

Another In-House Operation Gets Outsourced

Eppendorf’s Conical screw cap tubes in 15 mL and 50 mL complete a range of volume sizes that meet needs from 0.5 mL to 50 mL.

Conical Tube Reduces Contamination Risk

Will biosimilars share a compendial identity like generic drugs do?

Formulation and Drug Delivery